News Digest / Ticker: VRDN

Ticker: VRDN

08:14am, Wednesday, Aug 06, 2025

Viridian Therapeutics Reports High Q2 2025 Losses Amid Progress in Rare Disease Therapies

Viridian Therapeutics, Inc. (NASDAQ: VRDN) - Q2 2025 Financial Overview Viridian Therapeutics reported its financial results for the quarter ending June 30, 2025, highlighting both significant operational achievements and challenges. The company's focus lies in developing therapies for rare disea...

08:00am, Tuesday, May 06, 2025

Viridian Therapeutics Reports Q1 Losses Amid Ongoing Development for Rare Disease Treatments

Company Overview: Viridian Therapeutics, Inc. (NASDAQ: VRDN) Viridian Therapeutics, Inc. is a biopharmaceutical company actively engaged in the development of innovative treatments for serious and rare diseases, particularly focusing on therapies for Thyroid Eye Disease (TED) and engineered FcRn ...

08:48am, Tuesday, Sep 10, 2024

Premarket Movers: Apple Drops, Oracle Soars

Tuesday Premarket: Oracle jumps on earnings, HPE falls after funding news. Alibaba, Boot Barn, and Mission Produce rise. Learn why...